US-based analytics and AI firm Palantir, in partnership with Accenture, has been chosen as the winner of the highly coveted £480m Federated Data Platform (FDP) procurement. The decision, which had been widely anticipated, was finally signed off by ministers and is set to be publicly announced in the coming days.
Palantir, who currently provides services for FDP, faced stiff competition from other bidders, including Oracle and IBM. However, their strong track record and expertise in analytics made them the frontrunner.
The award of the FDP procurement, initially scheduled to be declared in September, faced delays as ministers sought greater evidence of support from within the system. In response to this demand, sixteen trust medical directors lent their support to FDP in a joint letter in October.
NHS England’s Chief Data and Analytics Officer, Ming Tang, recently confirmed at the AI and Data event organized by Digital Health that the procurement process was complete. The final sign-off for the contract award rested with ministers, and their approval has now been granted.
The Federated Data Platform is a crucial initiative that aims to revolutionize data management and analytics within the healthcare sector. It will provide a centralized platform for securely storing and analyzing vast amounts of health data, leading to more effective decision-making and improved patient outcomes.
FAQ:
Q: What is the Federated Data Platform (FDP)?
A: The Federated Data Platform is a project aimed at transforming data management and analytics in the healthcare sector. It will centralize the storage and analysis of health data, allowing for improved decision-making and better patient outcomes.
Q: Who were the main bidders for the FDP procurement?
A: The main bidders for the FDP procurement were Palantir (in partnership with Accenture), Oracle, and IBM.
Q: Why did the announcement of the FDP procurement winner face delays?
A: The announcement faced delays as ministers required further evidence of support within the system. This support was later provided by sixteen trust medical directors in a joint letter.